Kura Oncology Highlights New Clinical And Translational Data Supporting Darlifarnib As Potential Foundational Combination Platform For KRAS-Mutant Cancers And Other Targeted Therapy Settings

뉴스 본문을 불러오고 있어요.

Kura Oncology Highlights New Clinical And Translational Data Supporting Darlifarnib As Potential Foundational Combination Platform For KRAS-Mutant Cancers And Other Targeted Therapy Settings | 웨이프 WAPE

Kura Oncology Highlights New Clinical And Translational Data Supporting Darlifarnib As Potential Foundational Combination Platform For KRAS-Mutant Cancers And Other Targeted Therapy Settings

기사 요약

관련 종목

댓글 —